ESSA Pharma Inc (EPIX.OQ)
EPIX.OQ on NASDAQ Stock Exchange Capital Market
3.16USD
23 May 2018
3.16USD
23 May 2018
Change (% chg)
$-0.12 (-3.66%)
$-0.12 (-3.66%)
Prev Close
$3.28
$3.28
Open
$3.25
$3.25
Day's High
$3.25
$3.25
Day's Low
$3.16
$3.16
Volume
106
106
Avg. Vol
3,721
3,721
52-wk High
$51.00
$51.00
52-wk Low
$2.78
$2.78
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.51 | September | 25 May 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 3 | 3 | 2 | 2 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Jun-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Sep-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 1 | -0.51 | -0.51 | -0.51 | -- |
| Quarter Ending Jun-18 | 1 | -0.51 | -0.51 | -0.51 | -- |
| Year Ending Sep-18 | 3 | -1.90 | -1.60 | -2.31 | -- |
| Year Ending Sep-19 | 2 | -1.93 | -1.80 | -2.05 | -- |
Historical Surprises
Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | ||||
| Quarter Ending Mar-18 | -0.51 | -0.83 | 0.32 | -61.60 |
| Quarter Ending Sep-17 | -4.38 | -2.26 | 2.12 | -48.46 |
| Quarter Ending Jun-17 | -4.05 | -3.20 | 0.85 | -20.96 |
| Quarter Ending Mar-17 | -2.88 | -3.80 | 0.92 | -32.16 |
| Quarter Ending Dec-15 | -3.40 | -3.80 | 0.40 | -11.76 |
Consensus Estimates Trend
Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 0.00 | -- | -- | -- | -- |
| Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | -- | -- |
| Year Ending Sep-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Sep-19 | 0.00 | 0.00 | 0.00 | -- | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | -0.51 | -- | -- | -- | -- |
| Quarter Ending Jun-18 | -0.51 | -0.51 | -0.51 | -- | -- |
| Year Ending Sep-18 | -1.90 | -1.90 | -1.90 | -1.70 | -- |
| Year Ending Sep-19 | -1.93 | -1.93 | -1.93 | -1.80 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Year Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Sep-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Year Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Sep-19 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- BRIEF-Essa Pharma Qtrly Loss Per Share Of $0.83
- BRIEF-ESSA Pharma Inc. Regains Compliance With Nasdaq Listing Requirements
- BRIEF-Essa Pharma Files For Resale Of 113.9 Mln Common Shares By Selling Shareholders
- BRIEF-Essa Pharma Qtrly Loss Per Share $0.07
- BRIEF-Essa Pharma Files For Offering Of About 113.9 Million Common Shares That May Be Offered For Resale By Selling Shareholders